Use of calcitonin in the treatment of bone pain associated with osteoporosis
- 1 March 1991
- journal article
- review article
- Published by Springer Nature in Calcified Tissue International
- Vol. 49 (S2) , S9-S13
- https://doi.org/10.1007/bf02561370
Abstract
In osteoporosis, calcitonin exerts an analgesic effect that is unrelated to its effect on bone. Although the precise mechanism has yet to be clarified, there is some evidence that the analgesic effect of calcitonin may be mediated through the endogenous opioid system. The intranasal administration of calcitonin seems to be more effective in producing analgesia than parenteral administration.Keywords
This publication has 9 references indexed in Scilit:
- ANALGESIC EFFECT OF INTRANASAL SALMON-CALCITONIN IN THE TREATMENT OF OSTEOPOROTIC VERTEBRAL FRACTURES1989
- [Calcitonin in acute pain due to vertebral fracture in osteoporosis. Cooperative study].1987
- Salmon calcitonin in the therapy of corticoid-induced osteoporosisEuropean Journal of Clinical Pharmacology, 1987
- Calcitonin Induced Increase in ACTH, β-Endorphin and Cortisol SecretionHormone and Metabolic Research, 1986
- Migraine Prophylaxis with Salmon Calcitonin: a Cross‐over Double‐blind, Placebo‐controlled StudyHeadache: The Journal of Head and Face Pain, 1986
- Calcitonin gene-related peptide and its binding sites in the human central nervous system and pituitary.Proceedings of the National Academy of Sciences, 1985
- [Treatment of ordinary osteoporosis by the combination of salmon calcitonin-phosphorus and magnesium].1979
- Pain Mechanisms: A New TheoryScience, 1965